COMMUNIQUÉS West-GlobeNewswire

Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131
07/06/2018
MADISON, Wis., June 07, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments [...]
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
07/06/2018
Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) HACKENSACK, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), a leader in the [...]
Iovance Biotherapeutics Announces First Patient Dosed in Europe for Ongoing C-144-01 Phase 2 Trials in Metastatic Melanoma
07/06/2018
SAN CARLOS, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor infiltrating lymphocyte (TIL) technology [...]
Alder BioPharmaceuticals® Names Robert W. Azelby President and Chief Executive Officer
07/06/2018
Former executive at Juno Therapeutics and Amgen, Azelby brings deep operational and commercialization expertise BOTHELL, Wash., June 07, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) a [...]
Insmed to Present at Three June Conferences
07/06/2018
BRIDGEWATER, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that management will [...]
Vital Therapies to Present at the Jefferies 2018 Global Healthcare Conference
07/06/2018
SAN DIEGO, June 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced [...]
Atara Biotherapeutics Announces Appointment of Utpal Koppikar as Chief Financial Officer
07/06/2018
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
B-Temia and Wistron Join Forces to Launch Keeogo™ in Asia
07/06/2018
B-Temia and Wistron form B-Temia Asia to bring Keeogo™ to the Asian Market QUEBEC CITY, June 07, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotics technology company and market leader in human mobility, [...]
B-Temia et Wistron s'associent pour lancer Keeogo™ en Asie
07/06/2018
B-Temia et Wistron forment B-Temia Asia pour lancer Keeogo™ sur le marché asiatique QUÉBEC, 07 juin 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., une entreprise canadienne de technologie biorobotique et chef de file du marché [...]
HempAmericana Completes Construction of High-Potency Seed Augmentation Greenhouse
07/06/2018
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce the full completion of its new state-of-the-art greenhouse [...]
Summit Therapeutics plc : Result of AGM
07/06/2018
Summit Therapeutics plc ('Summit' or the "'Company') Result of Annual General Meeting Oxford, UK, and Cambridge, MA, US, 7 June 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that all resolutions [...]
Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke
07/06/2018
TMS-007 is designed to restore blood flow following acute stroke, with an extended treatment window versus current standard of care Biogen to pay $4 million upfront and $18 million upon exercise of the option, plus [...]
Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program
07/06/2018
New Tools Unveiled at ASM Annual Meeting Enable Microbiologists to Do More, See More Than Ever Before MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California Inc., (Nasdaq:PACB) today [...]
Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox
07/06/2018
DURHAM, N.C., June 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that the U.S. Food and Drug Administration [...]
IMV Inc. Appoints Julia P. Gregory to Board of Directors
07/06/2018
HALIFAX, Nova Scotia, June 07, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq:IMV) (TSX:IMV), a clinical stage immunotherapy company, announced today the addition of Julia P. Gregory to the [...]
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
07/06/2018
Zafgen, Inc. also announces the retirements of Dr. Bruce Booth and Ms. Frances Heller from its Board of Directors BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. , (Nasdaq:ZFGN) , a clinical-stage [...]
MPX Bioceutical Corporation to Host Investor Conference Call on June 12, 2018
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to update investors on the recently completed US$40 million convertible [...]
Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today the [...]
FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease
07/06/2018
SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, today announced the completion of patient enrollment in the Phase 3 studies supporting the U.S. new drug [...]

Pages